First cancer ‘living drug’ gets go-ahead

The US has approved the first treatment to redesign a patient’s own immune system so it attacks cancer. The regulator – the US Food and Drug Administration – said its decision was a “historic” moment and medicine was now “entering a new frontier”. The company Novartis is charging $475,000 (£367,000) for the “living drug” therapy, which leaves 83% of people free of a type of blood cancer. Doctors in the UK said the announcement was an exciting step forward. The living drug is tailor-made to each patient, unlike conventional therapies…

Read More

Drug Treatment Could Add Years To A Dog’s Life

A trial to extend the lifespan of pet dogs has shown promise – with marked improvement in heart health. Anti-rejection medicine rapamycin was given to dogs in phase one trials by evolutionary geneticists at the University of Washington, the Daily Telegraph reports. It is usually given to humans who’ve had a kidney transplant, but was found to extend the life of mice by more than 25%. A similar impact on dogs would give our canine companions up to an extra four years of life. Trials on 24 middle-aged golden retrievers,…

Read More